Technical Analysis for CRVO - CervoMed Inc.

Grade Last Price % Change Price Change
F 9.64 -4.37% -0.44
CRVO closed down 4.37 percent on Wednesday, November 20, 2024, on 74 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -4.37%

   Recent Intraday Alerts

Alert Time
Rose Above Lower Bollinger Band about 21 hours ago
Up 2% about 21 hours ago
Up 1% about 21 hours ago
Down 3% 2 days ago
Rose Above Lower Bollinger Band 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CervoMed Inc. is a clinical-stage biotechnology company advancing CNS-focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The Company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha (p38a). Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in dementia with Lewy bodies (DLB) and certain other major neurological disorders. Neflamapimod is currently being evaluated in a Phase 2b study in patients with DLB.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Development Cancer Treatment Oncology Chemotherapy Radiation Ophthalmology Oxygen Dermatology Macular Degeneration Blastoma Glioblastoma Radiation Therapy Signal Transduction Cancer Cell Acne Brain Tumor mTOR Glioblastoma Multiforme Oncology Applications Acne Vulgaris

Is CRVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.3789
52 Week Low 5.85
Average Volume 84,635
200-Day Moving Average 17.17
50-Day Moving Average 13.58
20-Day Moving Average 12.15
10-Day Moving Average 11.21
Average True Range 1.09
RSI (14) 27.54
ADX 17.51
+DI 11.26
-DI 26.35
Chandelier Exit (Long, 3 ATRs) 11.35
Chandelier Exit (Short, 3 ATRs) 12.58
Upper Bollinger Bands 14.62
Lower Bollinger Band 9.68
Percent B (%b) -0.01
BandWidth 40.69
MACD Line -0.96
MACD Signal Line -0.73
MACD Histogram -0.2289
Fundamentals Value
Market Cap 54.7 Million
Num Shares 5.67 Million
EPS -5.59
Price-to-Earnings (P/E) Ratio -1.72
Price-to-Sales 11.27
Price-to-Book 5.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.25
Resistance 3 (R3) 11.31 10.85 10.98
Resistance 2 (R2) 10.85 10.44 10.81 10.89
Resistance 1 (R1) 10.24 10.19 10.01 10.18 10.80
Pivot Point 9.78 9.78 9.66 9.74 9.78
Support 1 (S1) 9.17 9.37 8.94 9.11 8.48
Support 2 (S2) 8.71 9.12 8.67 8.39
Support 3 (S3) 8.10 8.71 8.30
Support 4 (S4) 8.04